VistaPre-T
No independent trials of this product yet — its evidence is the literature on what it is made of. The maker’s figures below are labelled and unverified. Strength reflects the active substance, not the brand.
What the manufacturer claims
FreeCaptured from the product page, typed and attributed — the producer’s own statements, checked against the literature below.
Claim ↔ evidence ledger
Verdict free · receipts in PowerEach claim against the studies on the active substance, with the funding split. Open a row for the studies behind the verdict.
Evidence — on the active substance
Table free · full-text in PowerAnalysis & tools
◆ PowerThe working map a maker won’t give you — built only from the evidence on this page. Nothing here is marketing.
Open the analyst workbench
Dose benchmark, the independent-vs-sponsored split, the pooled meta-analysis effects, the contradictions and the gaps — all derived from the studies above.
- Dose: label vs effective trial range vs EU max
- Independence-of-evidence breakdown
- Pooled meta-analysis effect sizes
- Compare · CSV / JSON · API
Dose benchmark
Neither the active composition nor a recommended dose was disclosed in retrievable sources.
Independence of evidence
Regulatory status
Discussion — grounded in the evidence
- Evidence strength: none. VistaPre-T is the honestly thin case in AB Vista’s range — only manufacturer marketing was retrievable, with no independent or peer-reviewed efficacy data.
- Its claims — improving fibre use, releasing more energy from roughages, and improving milk/meat performance — are currently unverified against independent evidence.
- The active composition, mechanism and recommended dose are not disclosed in retrievable sources.
- Even the broader exogenous-fibrolytic-enzyme literature in ruminants is mixed and does not name this product, so no substance-level read-across can be made with confidence.
- Listed for completeness and transparency; the verdict is 'insufficient independent evidence', not a negative finding.
Gaps: No independent, peer-reviewed efficacy data were retrievable; only AB Vista marketing pages were found. The active substance, mechanism and recommended dose are not disclosed in retrievable sources. The general exogenous-fibrolytic-enzyme literature in ruminants is itself mixed/inconsistent and does not name this product.
Manufacturer’s stated mechanism (their words): Marketed as improving the use of dietary fibre so that more energy is released from roughages and fibrous co-products, to improve efficiency and performance (primarily in ruminants). The exact active composition and mechanism are not disclosed in the retrievable material, and no independent description was found.
Compare & export
Put this beside alternatives on the same active substance (e.g. HMBi / other rumen-protected methionine), and take the data with you.